Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Novartis

04:14 EST 24th January 2019 | BioPortfolio

Here are the most relevant search results for "Novartis" found in our extensive news archives from over 250 global news sources.

More Information about Novartis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Novartis for you to read. Along with our medical data and news we also list Novartis Clinical Trials, which are updated daily. BioPortfolio also has a large database of Novartis Companies for you to search.

Showing News Articles 1–25 of 100 from Novartis

Monday 10th December 2018

Bringing real change to people

Since 2012, Thierry Diagana has served as Head of the Novartis Institute for Tropical Diseases (NITD), a small-molecule drug discovery research institute within the Novartis Institutes for BioMedical Research. In this role, he is focused on discovering new medicines that contribute to the elimination of infectious diseases like malaria. He described his team’s progress during a recent conversati...

Friday 7th December 2018

Women in Science: Susanne Schaffert

We recently chatted with Susanne Schaffert, president of Advanced ...

Tuesday 4th December 2018

Flexibility at Novartis: Peter Canavan

The “Flexibility at Novartis” series spotlights associates who have one thing in common: They work flexibly. As a result, they are able to manage the demands of their work and private lives. Flexible working can boost employee engagement while increasing efficiency and productivity. This series provides a glimpse into flexible working at Novartis. Peter Canavan serves as Head Novartis Country...

Monday 3rd December 2018

Flexibility at Novartis: Deepti Mittal

The “Flexibility at Novartis” series spotlights associates who have one thing in common: They work flexibly. As a result, they are able to manage the demands of their work and private lives. Flexible working can boost employee engagement while increasing efficiency and productivity. This series provides a glimpse into flexible working at Novartis. Deepti Mittal serves as a Senior Finance Mana...

Friday 30th November 2018

From patient to patient advocate: how a cancer diagnosis fueled a new career path

Almost 30 years ago, Elyse Spatz Caplan’s oldest son hopped on a bus to go to summer camp while she drove to the hospital for surgery. A young mom of 3 boys under the age of 8, she had recently been diagnosed with breast cancer and was dealing with feelings of unease and uncertainty about the future.While at Albert Einstein Medical Center in Philadelphia, Pennsylvania, Spatz Caplan received the ...

Tuesday 30th October 2018

Artificial intelligence decodes cancer pathology images

For 150 years, pathologists have been looking through microscopes at tissue samples mounted on slides to diagnose cancer. Each assessment is weighty: Does this patient have cancer or not?The job of a pathologist is daunting. A single slide could contain hundreds of thousands of cells. Only a handful might be cancer. Inaccurate diagnosis rates range from 3-9% of cases, according to a recent review....

Monday 29th October 2018

The importance of caregivers

Behind every cancer patient, there is likely a caregiver whose critical role is often overlooked. By helping patients understand and ...

Friday 26th October 2018

Flexibility at Novartis: Robert Gschwentner and Stefan Lackner

The “Flexibility at Novartis” series spotlights associates who have one thing in common: They work flexibly. As a result, they are able to manage the demands of their work and private lives. Flexible working can boost employee engagement while increasing efficiency and productivity. This series provides a glimpse into flexible working at Novartis.Robert Gschwentner and Stefan Lackner have a jo...

Flexibility at Novartis: Ana Graf

The “Flexibility at Novartis” series spotlights associates who have one thing in common: They work flexibly. As a result, they are able to manage the demands of their work and private lives. Flexible working can boost employee engagement while increasing efficiency and productivity. This series provides a glimpse into flexible working at Novartis. Ana Graf serves as Senior Global Program Head...

Thursday 25th October 2018

The realities of living with premenopausal metastatic breast cancer

Helga: shifting passions to help others following diagnosisAt age 35, Helga was diagnosed with early-stage breast cancer. She thought, “OK, I’m going to get cured and move on.” As she was finishing her treatment, Helga’s doctor told her in passing that there was a chance that her breast cancer could come back – but that was the end of the discussion. She recalls being told to not spend t...

Friday 19th October 2018

Women in Science: Wendy Winckler

In this installment of “Novartis ...

Women in Science: Jean Silveri

Ph.D. candidate-turned-lawyer Jean Silveri serves as Global ...

Women in Science: Jennifer Allport-Anderson

Jennifer Allport-Anderson, a cardiovascular researcher at the Novartis Institutes for BioMedical Research (NIBR), reflects on ...

Thursday 18th October 2018

Women in Science: Cyndy Grosskreutz

Cyndy Grosskreutz, a physician-scientist who serves as Global Head of Ophthalmology Research at Novartis, left academia to join the company. In ...

Women in Science: Alexandra Bach-Weidmuller

Alexandra Bach-Weidmuller took a nontraditional ...

Thursday 4th October 2018

Women in Science: Marjorie Eiref

Many people who work in the healthcare industry do so because they want to help people. For Marjorie Eiref, family also plays a ...

On being and becoming a data science company

When Bertrand Bodson decided to join Novartis, his friends were surprised. You like a fast pace, they ...

Wednesday 29th August 2018

The ABCDEs of melanoma prevention and detection

It is ...

Tuesday 21st August 2018

Teaming up with academia to discover medicines

Humans carrying a certain rare combination of two genetic mutations experience something unexpected. One mutation causes sickle cell disease, a lifelong and debilitating form of anemia that affects millions worldwide. The other appears to cancel out the first. Individuals with both mutations show no symptoms of disease.Hematologist Stuart Orkin and other experts in the field think that the second ...

Researchers boost understanding of T-cell therapy in blood cancer

Most children and young adults with acute lymphoblastic leukemia (ALL) who received a Novartis T-cell immunotherapy in two clinical trials responded to the treatment1. Scientists typically didn’t find any molecular traces of the aggressive blood cancer after the treatment, tisagenlecleucel, a form of chimeric antigen receptor T-cell (CAR-T) therapy in which the patient’s own T-cells are geneti...

Neuroscientists target Alzheimer’s “silent stage”

The latest research into what is known as the “silent stage” of Alzheimer’s disease has prompted many experts to believe that early intervention may offer the best chance of therapeutic success.The “silent stage” of Alzheimer’s concerns what goes on inside the brain before symptoms appear and is today a major focus of current research. Neuroscientists are particularly interested in the...

Thursday 2nd August 2018

New drug manufacturing tools change pharma chemistry

Most medicines are made the old-fashioned way. In fact, the process hasn’t changed much for over a hundred years. Engineers mix large amounts of chemical materials together in industrial-sized vats, the way a baker might make a very large batch of cookies.It’s a reliable system, but not very flexible.Recent advances in chemical engineering and automation, however, have ushered in a new era for...

Wednesday 1st August 2018

Embracing big data to understand complex diseases

In 1967, in response to a life-shortening heart disease epidemic in the Western world, the Icelandic Heart Association (IHA) launched the Reykjavik Study, a research program intended to get at the roots of heart disease and find ways to stop it. Researchers recruited 30 000 Icelanders to join the study, which morphed into another study that still runs to this day.Researchers from Novartis and IHA ...

Monday 23rd July 2018

Discovery gives cystic fibrosis researchers new direction

When scientists discovered the gene that causes cystic fibrosis in 1989, they were optimistic that a cure was on the horizon. As the years passed by, hundreds of mutations were identified in the gene, but new treatments were slow to emerge and a cure has yet to materialize. One major reason for the delay is that scientists have had trouble figuring out precisely where the gene is active. Now they ...

Friday 29th June 2018

Drug development gets big data analytics boost

Today, the power of data analytics is informing strategies and business practices across industries. Football clubs are chasing players with specific skills to strengthen a side’s qualities, and Formula 1 teams are analyzing every turn of the wheel to squeeze out milliseconds to win races. The promise of big data and advanced analytics, which has been fueled by a quantum leap in computing over t...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks